StocksMedium•4 November 2026•
1 min read
Massachusetts Hospitals Sue Eli Lilly Over Federal Drug Discount Program
Key Facts
1Five Massachusetts hospitals filed a lawsuit against Eli Lilly alleging violations of the federal 340B drug discount program law.
2Hospitals allege the company withheld tens of millions of dollars in discounts due to their refusal to share patient data.
Five Massachusetts hospitals filed a lawsuit against Eli Lilly alleging violations of the federal 340B drug discount program law. Boston.com reported that the hospitals, including Massachusetts General Hospital and Brigham and Women's Hospital, accuse the company of withholding tens of millions of dollars in discounts due to their refusal to share patient data via a third-party platform.
The hospitals allege in the suit that Eli Lilly is leveraging its monopoly power to demand privacy-protected patient data in exchange for participation in the federal program. Shares of Eli Lilly (LLY) closed at $1409.38 on November 3, 2026, as legal challenges regarding the 340B program present significant regulatory risks for major pharmaceutical firms.